210 related articles for article (PubMed ID: 20888443)
1. PTPN22 1858C>T polymorphism is strongly associated with rheumatoid arthritis but not with a response to methotrexate therapy.
Majorczyk E; Pawlik A; Kuśnierczyk P
Int Immunopharmacol; 2010 Dec; 10(12):1626-9. PubMed ID: 20888443
[TBL] [Abstract][Full Text] [Related]
2. The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico.
Torres-Carrillo NM; Ruiz-Noa Y; Martínez-Bonilla GE; Leyva-Torres SD; Torres-Carrillo N; Palafox-Sánchez CA; Navarro-Hernández RE; Rangel-Villalobos H; Oregón-Romero E; Muñoz-Valle JF
Immunol Lett; 2012 Sep; 147(1-2):41-6. PubMed ID: 22743847
[TBL] [Abstract][Full Text] [Related]
3. Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma.
Majorczyk E; Jasek M; Płoski R; Wagner M; Kosior A; Pawlik A; Obojski A; Luszczek W; Nowak I; Wiśniewski A; Kuśnierczyk P
Eur J Hum Genet; 2007 Oct; 15(10):1043-8. PubMed ID: 17579671
[TBL] [Abstract][Full Text] [Related]
4. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
Kokkonen H; Johansson M; Innala L; Jidell E; Rantapää-Dahlqvist S
Arthritis Res Ther; 2007; 9(3):R56. PubMed ID: 17553139
[TBL] [Abstract][Full Text] [Related]
5. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.
Chabchoub G; Teixiera EP; Maalej A; Ben Hamad M; Bahloul Z; Cornelis F; Ayadi H
Ann Hum Biol; 2009; 36(3):342-9. PubMed ID: 19343596
[TBL] [Abstract][Full Text] [Related]
6. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
7. 1858 C/T polymorphism of the protein tyrosine phosphatase nonreceptor 22 gene and rheumatoid arthritis risk in europeans: a meta-analysis.
Nong LM; Ren KW; Xu NW; Zhou D
Arch Med Res; 2011 Nov; 42(8):698-702. PubMed ID: 22209972
[TBL] [Abstract][Full Text] [Related]
8. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
van Oene M; Wintle RF; Liu X; Yazdanpanah M; Gu X; Newman B; Kwan A; Johnson B; Owen J; Greer W; Mosher D; Maksymowych W; Keystone E; Rubin LA; Amos CI; Siminovitch KA
Arthritis Rheum; 2005 Jul; 52(7):1993-8. PubMed ID: 15986374
[TBL] [Abstract][Full Text] [Related]
9. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
[TBL] [Abstract][Full Text] [Related]
10. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Cáliz R; Ortego-Centeno N; Jiménez-Alonso J; Pascual-Salcedo D; Balsa A; de Pablo R; Nuñez-Roldan A; González-Escribano MF; Martín J
Arthritis Rheum; 2005 Jan; 52(1):219-24. PubMed ID: 15641066
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
12. The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material.
Viken MK; Olsson M; Flåm ST; Førre O; Kvien TK; Thorsby E; Lie BA
Tissue Antigens; 2007 Sep; 70(3):190-7. PubMed ID: 17661906
[TBL] [Abstract][Full Text] [Related]
13. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.
Harrison P; Pointon JJ; Farrar C; Brown MA; Wordsworth BP
Rheumatology (Oxford); 2006 Aug; 45(8):1009-11. PubMed ID: 16490755
[TBL] [Abstract][Full Text] [Related]
14. Association of the PTPN22 gene polymorphism with autoantibody positivity in Turkish rheumatoid arthritis patients.
Ates A; Karaaslan Y; Karatayli E; Ertuğrul E; Aksaray S; Türkyilmaz A; Ozet G
Tissue Antigens; 2011 Jul; 78(1):56-9. PubMed ID: 21506938
[TBL] [Abstract][Full Text] [Related]
15. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
[TBL] [Abstract][Full Text] [Related]
16. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
17. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis.
Orozco G; Pascual-Salcedo D; López-Nevot MA; Cobo T; Cabezón A; Martín-Mola E; Balsa A; Martín J
Rheumatology (Oxford); 2008 Feb; 47(2):138-41. PubMed ID: 18156150
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population.
Newman WG; Zhang Q; Liu X; Walker E; Ternan H; Owen J; Johnson B; Greer W; Mosher DP; Maksymowych WP; Bykerk VP; Keystone EC; Amos CI; Siminovitch KA
Arthritis Rheum; 2006 Dec; 54(12):3820-7. PubMed ID: 17133579
[TBL] [Abstract][Full Text] [Related]
19. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
